Clinical Trial Update: Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and pharmacokinetics of Minocin (minocycline) for injection in subjects with renal insufficiency was terminated; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure
• Renal Insufficiency

Drugs mentioned

• MINOCIN (MINOCYCLINE HYDROCHLORIDE)

Snippet

Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | Conditions: Renal Insufficiency, Acute, Renal Insufficiency, Chronic | Phase 1 | Status: TERMINATED | Results posted: 2019-07-24